Corcept Therapeutics Stock (NASDAQ:CORT)
Previous Close
$59.60
52W Range
$20.84 - $61.66
50D Avg
$44.32
200D Avg
$32.12
Market Cap
$6.19B
Avg Vol (3M)
$902.43K
Beta
0.46
Div Yield
-
CORT Company Profile
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.
CORT Performance
Peer Comparison
Ticker | Company |
---|---|
ANAB | AnaptysBio, Inc. |
DICE | DICE Therapeutics, Inc. |
NUVB | Nuvation Bio Inc. |
IDYA | IDEAYA Biosciences, Inc. |
DYN | Dyne Therapeutics, Inc. |
NXTC | NextCure, Inc. |
MLYS | Mineralys Therapeutics, Inc. |
HALO | Halozyme Therapeutics, Inc. |
EWTX | Edgewise Therapeutics, Inc. |
MGTX | MeiraGTx Holdings plc |
ERAS | Erasca, Inc. |
CERE | Cerevel Therapeutics Holdings, Inc. |
SNSE | Sensei Biotherapeutics, Inc. |
GRPH | LENZ Therapeutics, Inc. |
KROS | Keros Therapeutics, Inc. |
GLUE | Monte Rosa Therapeutics, Inc. |
AGIO | Agios Pharmaceuticals, Inc. |
INSM | Insmed Incorporated |
CYTK | Cytokinetics, Incorporated |
KRTX | Karuna Therapeutics, Inc. |
FIXX | Q32 Bio Inc. |
RARE | Ultragenyx Pharmaceutical Inc. |
MACK | Merrimack Pharmaceuticals, Inc. |